Juan, As you know, Provenge is the brand name for sipuleucel-T, an autologous cellular immunotherapy used to treat late-stage prostate cancer that no longer responds to hormone therapy (metastatic castrate resistant).

@ken82 posted information about the approval of this drug here https://connect.mayoclinic.org/comment/255858/, but I'm not sure if he has had it offered as a treatment. While we wait to see if other members have experience with Provenge, you may appreciate this information:

- Provenge for Treatment of Late-Stage Prostate Cancer https://www.healthline.com/health/prostate-cancer/provenge

When will you start this treatment? Have you already had white blood cells removed to create the vaccine for you?